WMSA
Weiss Multi-Strategy Advisers Portfolio holdings
AUM
$3.94B
1-Year Return
29.08%
This Quarter Return
+0.82%
1 Year Return
+29.08%
3 Year Return
+75.24%
5 Year Return
+223.81%
10 Year Return
+334.33%
AUM
$2.76B
AUM Growth
-$259M
(-8.6%)
Cap. Flow
-$247M
Cap. Flow
% of AUM
-8.95%
Top 10 Holdings %
Top 10 Hldgs %
23.4%
Holding
623
New
139
Increased
99
Reduced
129
Closed
162
Top Buys
| 1 |
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
|
+$51.2M |
| 2 |
VICI Properties
VICI
|
+$49.7M |
| 3 |
WRI
Weingarten Realty Investors
WRI
|
+$46.5M |
| 4 |
Ventas
VTR
|
+$41.5M |
| 5 |
EastGroup Properties
EGP
|
+$37.1M |
Top Sells
| 1 |
Regency Centers
REG
|
+$60.1M |
| 2 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$52.4M |
| 3 |
Douglas Emmett
DEI
|
+$51.5M |
| 4 |
Mid-America Apartment Communities
MAA
|
+$45.1M |
| 5 |
Alaska Air
ALK
|
+$44.9M |
Sector Composition
| 1 | Real Estate | 38.35% |
| 2 | Technology | 12.05% |
| 3 | Financials | 8.33% |
| 4 | Utilities | 8.19% |
| 5 | Industrials | 6.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALBO
301
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $1.13M | 0.03% |
35,000
-25,000
| -42% | -$806K |
|
302
Vanda Pharmaceuticals
VNDA
$269M
| $1.13M | 0.03% |
80,000
-5,000
| -6% | -$70.4K |
|
303
LivePerson
LPSN
$95.7M
| $1.12M | 0.03% |
40,000
+5,000
| +14% | +$140K |
|
|
TIVO
304
DELISTED
Tivo Inc
TIVO
| $1.11M | 0.03% |
150,000
+100,000
| +200% | +$737K |
|
|
GLOG
305
DELISTED
GASLOG LTD
GLOG
| $1.08M | 0.03% |
75,000
+49,500
| +194% | +$713K |
|
|
ENLC
306
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $1.06M | 0.03% |
+104,900
| New | +$1.06M |
|
307
Intuitive Surgical
ISRG
$168B
| $1.05M | 0.03% |
6,000
-3,000
| -33% | -$525K |
|
|
ICPT
308
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $1.03M | 0.03% |
13,000
+5,000
| +63% | +$398K |
|
309
Saba Closed-End Funds ETF
CEFS
$318M
| $1.02M | 0.03% |
+50,000
| New | +$1.02M |
|
|
MYOK
310
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $1M | 0.03% |
20,000
-5,000
| -20% | -$251K |
|
311
KeyCorp
KEY
$21B
| $976K | 0.03% |
55,000
-165,000
| -75% | -$2.93M |
|
312
Parsons
PSN
$8.01B
| $974K | 0.03% |
+26,420
| New | +$974K |
|
|
SAFM
313
DELISTED
Sanderson Farms Inc
SAFM
| $956K | 0.03% |
7,000
-7,078
| -50% | -$967K |
|
|
CLVS
314
DELISTED
Clovis Oncology, Inc.
CLVS
| $892K | 0.02% |
60,000
+30,000
| +100% | +$446K |
|
315
Ryder
R
$7.67B
| $875K | 0.02% |
+15,000
| New | +$875K |
|
316
Delta Air Lines
DAL
$39.6B
| $851K | 0.02% |
15,000
-172,000
| -92% | -$9.76M |
|
317
Union Pacific
UNP
$129B
| $846K | 0.02% |
5,000
-4,500
| -47% | -$761K |
|
|
CNR
318
Core Natural Resources, Inc.
CNR
$3.73B
| $838K | 0.02% |
31,499
-501
| -2% | -$13.3K |
|
|
EPZM
319
DELISTED
Epizyme, Inc
EPZM
| $816K | 0.02% |
65,000
-10,000
| -13% | -$126K |
|
320
STAAR Surgical
STAA
$1.37B
| $808K | 0.02% |
+27,500
| New | +$808K |
|
|
AUTL
321
Autolus Therapeutics
AUTL
$381M
| $805K | 0.02% |
50,000
+20,000
| +67% | +$322K |
|
|
GBT
322
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $789K | 0.02% |
+15,000
| New | +$789K |
|
|
TUFN
323
DELISTED
Tufin Software Technologies Ltd.
TUFN
| $777K | 0.02% |
+30,000
| New | +$777K |
|
324
Insmed
INSM
$31B
| $768K | 0.02% |
30,000
-12,000
| -29% | -$307K |
|
325
Sarepta Therapeutics
SRPT
$1.85B
| $760K | 0.02% |
5,000
-3,000
| -38% | -$456K |
|